Hedge Fund - Lynx1 Capital Management
Tscan Therapeutics Inc. (TCRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $8,019,148 | 1.62% | 8,019,148 | $1.45 |
| 2 | 2025 - Q3 (2025-09-30) | $14,300,372 | 2.91% | 7,857,347 | $1.77 |
| 3 | 2025 - Q2 (2025-06-30) | $11,393,153 | 3.29% | 7,857,347 | $1.44 |
| 4 | 2025 - Q1 (2025-03-31) | $7,393,139 | 2.65% | 5,357,347 | $2.16 |
| 5 | 2024 - Q4 (2024-12-31) | $16,286,335 | 6.1% | 5,357,347 | $4.53 |
| 6 | 2024 - Q3 (2024-09-30) | $26,018,508 | 9.21% | 5,224,600 | $6.03 |
| 7 | 2024 - Q2 (2024-06-30) | $30,563,910 | 11.04% | 5,224,600 | $7.88 |
| 8 | 2024 - Q1 (2024-03-31) | $41,483,324 | 10.68% | 5,224,600 | $6.29 |
| 9 | 2023 - Q4 (2023-12-31) | $30,459,418 | 11.97% | 5,224,600 | $4.58 |
| 10 | 2023 - Q3 (2023-09-30) | $13,374,976 | 8.84% | 5,224,600 | $2.33 |
| 11 | 2023 - Q2 (2023-06-30) | $13,061,500 | 8.55% | 5,224,600 | $2.68 |
The displayed share prices are average quarterly stock market prices.